Search - Prime Therapeutics
Navigate to
-
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...
Prime Article: Perspectives -
Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care...
PA Sub-Categories: Specialty drugs Prime Article: Perspectives